HHS and other federal agencies announced a new public-private healthcare partnership between the U.S. and China in conjunction with the state visit by Chinese President Hu Jintao. The initiative is aimed at fostering cooperation in research, training and regulation. The initial U.S. participants will include Pfizer, Medtronic, Abbott Laboratories and Johnson & Johnson, as well as AdvaMed, a trade group for devicemakers, and the Pharmaceutical Research and Manufacturers of America, which represents drugmakers. “The economic and social development of any nation depends on the health and productivity of its people,” said HHS Secretary Kathleen Sebelius said in a news release. Also participating on behalf of the U.S. government along with HHS are the Trade and Development Agency and the Commerce Department. “The partnership will draw its strength from U.S. companies strategically working together to help China achieve its development goals that will open new export markets for U.S. goods and services,” Commerce Secretary Gary Locke said in the release.
Late News: New healthcare partnership between U.S. and China
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.